
PCRX vs DMRA
$PCRX vs $DMRA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
PCRX vs DMRA: trend, levels and the market
One year to 2026-11-16, against the S&P 500 (+9.3%). Split-adjusted daily closes.
- ·Only PCRX beat the market over the past year, by 53.3%, while DMRA trailed the S&P 500 at +9.3% by 21.1%.
- ·The last month has flipped the order: DMRA leads over the month (+22% against +0.4%) even though PCRX leads over the year.
- ·PCRX sits closer to its support, 0.1% above it at $36.43, while DMRA is 9.7% above its own at $20.90.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
PCRX vs DMRA: the quick read
- ·PCRX is the larger company by market cap ($1.46B vs $1.44B).
- ·DMRA has been more active on our scanner (142 vs 1 alerts in 30 days).
- ·PCRX has the smaller float (37.1M vs 61.7M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·DMRA draws far more of our scanner's attention, 142 unusual-volume alerts in 30 days against 1, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching PCRX or DMRA? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing PCRX and DMRA on TheDesperateTrader.
- Is PCRX or DMRA the better stock?
- "Better" depends on your goal, and these two are not alike. PCRX is the larger company by market cap ($1.46B vs $1.44B). DMRA has been more active on our scanner (142 vs 1 alerts in 30 days). PCRX has the smaller float (37.1M vs 61.7M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between PCRX and DMRA?
- The differences that matter: they are not in the same business - PCRX is pharmaceutical preparations and DMRA is pharmaceutical preparations; they are similar in size ($1.46B vs $1.44B); they trade at very different share prices ($36.48 vs $23.16); PCRX sits at 99% of its 52-week range against 36% for DMRA; our scanner flagged PCRX 1 times in the last 30 days against 142 for DMRA. Everything above is measured from the latest completed session and SEC filings.
- Which of PCRX and DMRA is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is PCRX or DMRA in the stronger trend?
- PCRX is above its 50-day average of $31.39 and above its 200-day average of $25.73; DMRA is above its 50-day average of $22.04. PCRX leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading PCRX or DMRA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore PCRX and DMRA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.